News Detail

The S&P/ASX 200 Index (ASX: XJO) enjoyed a decisive relief rally this Tuesday, delivering some welcome respite for investors after yesterday's horror-show start to the week.

By the time trading wrapped up today, the ASX 200 had gained a healthy 1.09% after initially rallying even harder this morning (up 2% at one point). This session's rise leaves the index at 8,692.6 points.

This happy Tuesday for the Australian markets follows an optimistic start to the American trading week in the early hours of this morning (our time).

The Dow Jones Industrial Average Index (DJX: .DJI) returned from the weekend with a spring in its step, rising 0.5%.

The tech-heavy Nasdaq Composite Index (NASDAQ: .IXIC) was even more enthusiastic, gaining a rosy 1.38%.

But let's return to the local markets now and take stock of how the different ASX sectors were lifted, or not, by today's market tide.

Winners and losers

We saw only two sectors miss out on today's recovery rally.

The first of those was energy stocks. After being the island of green in a sea of red yesterday, energy reversed its role today. The S&P/ASX 200 Energy Index (ASX: XEJ) ended up taking a 2.91% hit.

Consumer staples shares were the other shunned corner of the market, with the S&P/ASX 200 Consumer Staples Index (ASX: XSJ) falling 0.31%.

But it was better news everywhere else.

Leading today's recovery were gold stocks. The All Ordinaries Gold Index (ASX: XGD) bounced back enthusiastically this session, shooting 2.05% higher.

Tech shares were back to black as well, as you can tell by the S&P/ASX 200 Information Technology Index (ASX: XIJ)'s 1.94% surge.

We could say the same for mining stocks. The S&P/ASX 200 Materials Index (ASX: XMJ) soared 1.87% higher today.

Healthcare shares didn't miss out either, with the S&P/ASX 200 Healthcare Index (ASX: XHJ) rallying 1.76%.

Financial stocks also ran hot. The S&P/ASX 200 Financials Index (ASX: XFJ) galloped up 1.31% this Tuesday.

Consumer discretionary shares were in demand too, evident by the S&P/ASX 200 Consumer Discretionary Index (ASX: XDJ)'s 1.27% jump.

Next came real estate investment trusts (REITs). The S&P/ASX 200 A-REIT Index (ASX: XPJ) had lifted 0.73% by the closing bell.

Industrial stocks got a reprieve, with the S&P/ASX 200 Industrials Index (ASX: XNJ) bouncing up 0.67%.

Communications shares were a little less enthusiastic. The S&P/ASX 200 Communication Services Index (ASX: XTJ) still managed a 0.14% bump, though.

Finally, utilities stocks managed to get over the line, illustrated by the S&P/ASX 200 Utilities Index (ASX: XUJ)'s 0.05% edge higher.

Top 10 ASX 200 shares countdown

Coming in on top of the tables this Tuesday was tech stock Life360 Inc (ASX: 360). Life360 shares rocketed 10.34% higher this session to close at $22.51 each.

This rise was a bit of a mystery, but we dove into possible catalysts here.

Here's how the other winners from today's trading landed their planes:

ASX-listed company	Share price	Price change
Life360 Inc (ASX: 360)	$22.51	10.34%
Neuren Pharmaceuticals Ltd (ASX: NEU)	$12.75	9.16%
DroneShield Ltd (ASX: DRO)	$4.02	8.36%
Telix Pharmaceuticals Ltd (ASX: TLX)	$11.00	7.84%
Bapcor Ltd (ASX: BAP)	$0.74	7.25%
Paladin Energy Ltd (ASX: PDN)	$11.95	6.70%
Pro Medicus Ltd (ASX: PME)	$139.69	6.23%
Sandfire Resources Ltd (ASX: SFR)	$16.60	5.80%
Mineral Resources Ltd (ASX: MIN)	$57.45	5.78%
NRW Holdings Ltd (ASX: NWH)	$5.82	5.24%

Our top 10 shares countdown is a recurring end-of-day summary that shows which companies made big moves on the day. Check in at Fool.com.au after the weekday market closes to see which stocks make the countdown.

Motley Fool contributor Sebastian Bowen has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended DroneShield, Life360, and Telix Pharmaceuticals and is short shares of DroneShield. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has positions in and has recommended Life360. The Motley Fool Australia has recommended Pro Medicus and Telix Pharmaceuticals. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The Motley Fool's purpose is to help the world invest, better. Click here now for your free subscription to Take Stock, The Motley Fool's free investing newsletter. Packed with stock ideas and investing advice, it is essential reading for anyone looking to build and grow their wealth in the years ahead. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson. 2026